Substanzen · Benzodiazepine und Thienodiazepine
Bromazolam
- Bevorzugter Name
- Bromazolam
- IUPAC-Name
- 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
- CAS-Nummer der Stammverbindung (Referenz)
- 71368-80-4
- Summenformel
- C17H13BrN4
- Molekulargewicht
- 353.2 g/mol
- InChIKey
- KCEIOBKDDQAYCM-UHFFFAOYSA-N
- PubChem
- CID 12562546
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
XLI-269 8-Bromo-alprazolam
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
Bromazolam
Rezeptor-Telemetrie & Wirkmechanismus
Non-selective high-affinity PAM across alpha1, alpha2, alpha3, and alpha5 GABA-A receptor subtypes (structurally the 8-bromo analogue of alprazolam).
Biotransformation & Active Metabolites
Hepatic CYP3A4 hydroxylation to alpha-hydroxybromazolam and 4-hydroxybromazolam followed by glucuronidation.
Zeitliche Pharmakokinetik
GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam) — 1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.
- Onset 20–45 min
- Peak Window 1.5–3 h
- Total Window 6–10 h
- Residual / Half-Life 8–18 h residual sedation
1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
0.5 mg
Subtle threshold receptor activity (GABA-A Positive Allosteric Modulator (8-Bromo-alprazolam)).
Minimal baseline autonomic shift.
0.5–1 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
1–2 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
2–4 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
4–5+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.
Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.
Hohes Risiko — Vermeiden
Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.
Vorsicht / Abschwächung
CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.
Isomeren- & Strukturvergleich
1 tablet = 1 mg sits at the light-to-common threshold; compared to Etizolam, Bromazolam is heavier on physical muscle relaxation and sedation and lasts 2–3 hours longer, while remaining significantly more forgiving per mg than Flualprazolam or Clonazolam.
Stabilität & Lagerung
Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.
Store sealed in a cool, dry, light-protected container away from humidity.
Cross-Tolerance & Dependence Profile
Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.
Chemische Struktur und Molekülprofil
Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine) ist eine Referenzverbindung aus der Stoffklasse Benzodiazepine und Thienodiazepine mit der Summenformel C17H13BrN4 und einer molaren Masse von 353.2 g/mol. Die Stammverbindung wird unter der CAS-Nummer 71368-80-4 sowie in der NCBI-PubChem-Datenbank unter CID 12562546 geführt (Standard-InChIKey: KCEIOBKDDQAYCM-UHFFFAOYSA-N).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört Bromazolam zur chemischen Klasse Benzodiazepine und Thienodiazepine. Diazepin-Referenzverbindung mit ausgeprägtem Risiko synergistischer Atemdepression in Kombination mit Opioiden, Alkohol oder anderen Sedativa. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)